Literature DB >> 20047487

Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population.

Carolina A Ponce1, Myriam Gallo, Rebeca Bustamante, Sergio L Vargas.   

Abstract

BACKGROUND: Increasing reports of Pneumocystis DNA in noninvasive respiratory specimens from immunocompetent asymptomatic adults and the characteristic lung tropism of Pneumocystis suggest that asymptomatic pulmonary infections with Pneumocystis occur after primary infection. However, studies searching for Pneumocystis in the autopsied lungs of healthy immunocompetent adults have not met with success.
METHODS: Lungs of people who died of violent causes (accidents, homicide, and suicide) and of nonviolent causes (diseases causing a rapid demise in the street) in Santiago, Chile-for whom an autopsy was legally required-were examined for Pneumocystis by nested polymerase chain reaction (PCR) DNA amplification of the mitochondrial large subunit ribosomal RNA-specific P. jirovecii gene and immunofluorescent microscopic analysis. Lung tissue concentration methods and analysis of approximately 3% of the weight of the right upper lobe (RUL) were needed to reach the sensitivity threshold of the assays. Individuals determined to be P. jirovecii negative after analysis of 3% of the RUL weight in the violent death group were confirmed to be negative by analyzing additional tissue, totaling 6%-7% of the RUL weight.
RESULTS: P. jirovecii was identified by nested PCR in 50 (64.9%) of 77 individuals (34 [61.8%] of 55 in the violent death group and 15 [78.9%] of 19 in the nonviolent death group; P > .05) and additionally by microscopic analysis in all individuals who tested positive for P. jirovecii DNA in the violent death group. Analysis of tissue beyond 3.0% of the RUL weight for the individuals who tested negative yielded consistently negative results.
CONCLUSIONS: A mild P. jirovecii pulmonary infection is prevalent in more than half of the general adult population. Our results strengthen the concept that immunocompetent adults develop frequent self-limited reinfections throughout life and participate in the circulation of P. jirovecii as an infective reservoir for susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047487     DOI: 10.1086/649868

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

2.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 3.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

4.  High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.

Authors:  Carolina A Ponce; Magali Chabé; Claudio George; Alejandra Cárdenas; Luisa Durán; Julia Guerrero; Rebeca Bustamante; Olga Matos; Laurence Huang; Robert F Miller; Sergio L Vargas
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

5.  Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?

Authors:  Omer Omer; Patrizia Cohen; Shuet Fong Neong; Geoffrey V Smith
Journal:  Frontline Gastroenterol       Date:  2014-09-22

6.  Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia.

Authors:  Steve M Taylor; Steven R Meshnick; William Worodria; Alfred Andama; J Lucian Davis; Adithya Cattamanchi; Saskia den Boon; Samuel D Yoo; Carol D Goodman; Laurence Huang
Journal:  Diagn Microbiol Infect Dis       Date:  2011-12-05       Impact factor: 2.803

7.  Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients.

Authors:  Sheila Sivam; Frank C Sciurba; Lorrie A Lucht; Yingze Zhang; Steven R Duncan; Karen A Norris; Alison Morris
Journal:  Diagn Microbiol Infect Dis       Date:  2011-09       Impact factor: 2.803

8.  Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia.

Authors:  Waleed Elsegeiny; Taylor Eddens; Kong Chen; Jay K Kolls
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

9.  Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism.

Authors:  Alexandros Kalkanis; Marc A Judson; Mark B Napier
Journal:  BMJ Case Rep       Date:  2013-11-28

10.  Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.

Authors:  Meghan E Fitzpatrick; John R Tedrow; Maria E Hillenbrand; Lorrie Lucht; Thomas Richards; Karen A Norris; Yingze Zhang; Frank C Sciurba; Naftali Kaminski; Alison Morris
Journal:  Microbiol Immunol       Date:  2014-03       Impact factor: 1.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.